The estimated Net Worth of Martina M.D. Flammer is at least 20.7 百万$ dollars as of 6 September 2024. Dr Flammer owns over 149,002 units of Insmed Inc stock worth over 18,563,695$ and over the last 5 years he sold INSM stock worth over 1,181,746$. In addition, he makes 934,413$ as Chief Medical Officer at Insmed Inc.
Dr has made over 16 trades of the Insmed Inc stock since 2022, according to the Form 4 filled with the SEC. Most recently he exercised 149,002 units of INSM stock worth 3,392,776$ on 6 September 2024.
The largest trade he's ever made was exercising 149,002 units of Insmed Inc stock on 6 September 2024 worth over 3,392,776$. On average, Dr trades about 15,553 units every 41 days since 2020. As of 6 September 2024 he still owns at least 255,136 units of Insmed Inc stock.
You can see the complete history of Dr Flammer stock trades at the bottom of the page.
Dr. Martina Flammer M.B.A., M.D. is the Chief Medical Officer at Insmed Inc.
As the Chief Medical Officer of Insmed Inc, the total compensation of Dr D at Insmed Inc is 934,413$. There are 5 executives at Insmed Inc getting paid more, with William Lewis having the highest compensation of 7,175,090$.
Dr D is 57, he's been the Chief Medical Officer of Insmed Inc since . There are 8 older and 15 younger executives at Insmed Inc. The oldest executive at Insmed Inc is Steinar Engelsen, 70, who is the Independent Director.
Martina's mailing address filed with the SEC is 700 US HIGHWAY 202/206, , BRIDGEWATER, NJ, 08807.
Over the last 22 years, insiders at Insmed Inc have traded over 46,121,705$ worth of Insmed Inc stock and bought 1,080,212 units worth 8,226,993$ . The most active insiders traders include Llc Fmr、William Lewis、Dennis M Lanfear. On average, Insmed Inc executives and independent directors trade stock every 38 days with the average trade being worth of 2,452,158$. The most recent stock trade was executed by Orlov S Nicole Schaeffer on 10 September 2024, trading 37,575 units of INSM stock currently worth 407,689$.
insmed is a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases. the company is dedicated to developing and bringing to market therapies that make a real difference in patients’ lives, while striving to understand and enhance the entire patient experience, from diagnosis and treatment to everyday living. headquartered in bridgewater, nj, we are a rapidly growing company with offices in seven countries.
Insmed Inc executives and other stock owners filed with the SEC include: